nodes	percent_of_prediction	percent_of_DWPC	metapath
Erlotinib—pancreatic cancer—retroperitoneal cancer	0.503	0.544	CtDrD
Erlotinib—kidney cancer—retroperitoneal cancer	0.421	0.456	CtDrD
Erlotinib—STK10—renal vein—retroperitoneal cancer	0.0177	0.232	CbGeAlD
Erlotinib—STK10—renal artery—retroperitoneal cancer	0.0119	0.156	CbGeAlD
Erlotinib—ULK3—ganglion—retroperitoneal cancer	0.00293	0.0385	CbGeAlD
Erlotinib—SLCO2B1—ganglion—retroperitoneal cancer	0.00158	0.0207	CbGeAlD
Erlotinib—AURKC—adrenal gland—retroperitoneal cancer	0.0013	0.0171	CbGeAlD
Erlotinib—HIPK4—testis—retroperitoneal cancer	0.00126	0.0166	CbGeAlD
Erlotinib—LTK—testis—retroperitoneal cancer	0.00125	0.0164	CbGeAlD
Erlotinib—JAK3—adrenal gland—retroperitoneal cancer	0.00121	0.0159	CbGeAlD
Erlotinib—TNK1—adrenal gland—retroperitoneal cancer	0.00111	0.0146	CbGeAlD
Erlotinib—AURKC—testis—retroperitoneal cancer	0.00108	0.0142	CbGeAlD
Erlotinib—EPHA6—testis—retroperitoneal cancer	0.000998	0.0131	CbGeAlD
Erlotinib—JAK3—testis—retroperitoneal cancer	0.000998	0.0131	CbGeAlD
Erlotinib—FLT3—adrenal gland—retroperitoneal cancer	0.000952	0.0125	CbGeAlD
Erlotinib—TNK1—testis—retroperitoneal cancer	0.000917	0.0121	CbGeAlD
Erlotinib—ABL2—adrenal gland—retroperitoneal cancer	0.000909	0.012	CbGeAlD
Erlotinib—MAP3K19—testis—retroperitoneal cancer	0.000907	0.0119	CbGeAlD
Erlotinib—LTK—lymph node—retroperitoneal cancer	0.000905	0.0119	CbGeAlD
Erlotinib—EGFR—adrenal gland—retroperitoneal cancer	0.000887	0.0117	CbGeAlD
Erlotinib—PIP4K2C—adrenal gland—retroperitoneal cancer	0.00086	0.0113	CbGeAlD
Erlotinib—ULK3—adrenal gland—retroperitoneal cancer	0.000821	0.0108	CbGeAlD
Erlotinib—FLT3—testis—retroperitoneal cancer	0.000788	0.0104	CbGeAlD
Erlotinib—STK10—kidney—retroperitoneal cancer	0.000787	0.0104	CbGeAlD
Erlotinib—AURKC—lymph node—retroperitoneal cancer	0.000781	0.0103	CbGeAlD
Erlotinib—MKNK1—adrenal gland—retroperitoneal cancer	0.000773	0.0102	CbGeAlD
Erlotinib—ABL2—testis—retroperitoneal cancer	0.000752	0.00989	CbGeAlD
Erlotinib—UGT1A1—kidney—retroperitoneal cancer	0.000744	0.00978	CbGeAlD
Erlotinib—EGFR—testis—retroperitoneal cancer	0.000734	0.00965	CbGeAlD
Erlotinib—SLK—adrenal gland—retroperitoneal cancer	0.000732	0.00963	CbGeAlD
Erlotinib—JAK3—lymph node—retroperitoneal cancer	0.000724	0.00952	CbGeAlD
Erlotinib—PIP4K2C—testis—retroperitoneal cancer	0.000711	0.00936	CbGeAlD
Erlotinib—ULK3—testis—retroperitoneal cancer	0.000679	0.00893	CbGeAlD
Erlotinib—TNK1—lymph node—retroperitoneal cancer	0.000664	0.00874	CbGeAlD
Erlotinib—MKNK1—testis—retroperitoneal cancer	0.000639	0.00841	CbGeAlD
Erlotinib—STK10—adrenal gland—retroperitoneal cancer	0.000637	0.00837	CbGeAlD
Erlotinib—SLK—testis—retroperitoneal cancer	0.000605	0.00796	CbGeAlD
Erlotinib—FLT3—lymph node—retroperitoneal cancer	0.000571	0.00751	CbGeAlD
Erlotinib—MAP2K5—adrenal gland—retroperitoneal cancer	0.000569	0.00748	CbGeAlD
Erlotinib—SLCO2B1—kidney—retroperitoneal cancer	0.000547	0.0072	CbGeAlD
Erlotinib—ABL2—lymph node—retroperitoneal cancer	0.000545	0.00717	CbGeAlD
Erlotinib—ABL1—kidney—retroperitoneal cancer	0.000543	0.00714	CbGeAlD
Erlotinib—EGFR—lymph node—retroperitoneal cancer	0.000532	0.007	CbGeAlD
Erlotinib—STK10—testis—retroperitoneal cancer	0.000526	0.00692	CbGeAlD
Erlotinib—PIP4K2C—lymph node—retroperitoneal cancer	0.000516	0.00678	CbGeAlD
Erlotinib—ULK3—lymph node—retroperitoneal cancer	0.000492	0.00648	CbGeAlD
Erlotinib—MAP2K5—testis—retroperitoneal cancer	0.00047	0.00618	CbGeAlD
Erlotinib—MKNK1—lymph node—retroperitoneal cancer	0.000463	0.0061	CbGeAlD
Erlotinib—CYP1B1—kidney—retroperitoneal cancer	0.000459	0.00604	CbGeAlD
Erlotinib—SLCO2B1—adrenal gland—retroperitoneal cancer	0.000442	0.00582	CbGeAlD
Erlotinib—SLK—lymph node—retroperitoneal cancer	0.000439	0.00577	CbGeAlD
Erlotinib—ABL1—adrenal gland—retroperitoneal cancer	0.000439	0.00577	CbGeAlD
Erlotinib—ALB—adrenal gland—retroperitoneal cancer	0.000405	0.00532	CbGeAlD
Erlotinib—STK10—lymph node—retroperitoneal cancer	0.000382	0.00502	CbGeAlD
Erlotinib—CYP1B1—adrenal gland—retroperitoneal cancer	0.000371	0.00489	CbGeAlD
Erlotinib—SLCO2B1—testis—retroperitoneal cancer	0.000366	0.00481	CbGeAlD
Erlotinib—ABL1—testis—retroperitoneal cancer	0.000363	0.00477	CbGeAlD
Erlotinib—CYP2C8—kidney—retroperitoneal cancer	0.000352	0.00463	CbGeAlD
Erlotinib—MAP2K5—lymph node—retroperitoneal cancer	0.000341	0.00448	CbGeAlD
Erlotinib—ALB—testis—retroperitoneal cancer	0.000335	0.0044	CbGeAlD
Erlotinib—CYP1A1—kidney—retroperitoneal cancer	0.000325	0.00427	CbGeAlD
Erlotinib—CYP3A5—kidney—retroperitoneal cancer	0.000318	0.00418	CbGeAlD
Erlotinib—CYP1B1—testis—retroperitoneal cancer	0.000307	0.00404	CbGeAlD
Erlotinib—ORM1—lymph node—retroperitoneal cancer	0.000277	0.00364	CbGeAlD
Erlotinib—ABCG2—adrenal gland—retroperitoneal cancer	0.000277	0.00364	CbGeAlD
Erlotinib—SLCO2B1—lymph node—retroperitoneal cancer	0.000265	0.00349	CbGeAlD
Erlotinib—ABL1—lymph node—retroperitoneal cancer	0.000263	0.00346	CbGeAlD
Erlotinib—ALB—lymph node—retroperitoneal cancer	0.000243	0.00319	CbGeAlD
Erlotinib—CYP3A4—kidney—retroperitoneal cancer	0.000238	0.00313	CbGeAlD
Erlotinib—CYP2C8—testis—retroperitoneal cancer	0.000235	0.00309	CbGeAlD
Erlotinib—CYP2D6—kidney—retroperitoneal cancer	0.000235	0.00308	CbGeAlD
Erlotinib—ABCG2—testis—retroperitoneal cancer	0.000229	0.00301	CbGeAlD
Erlotinib—CYP1B1—lymph node—retroperitoneal cancer	0.000223	0.00293	CbGeAlD
Erlotinib—ABCB1—kidney—retroperitoneal cancer	0.000169	0.00222	CbGeAlD
Erlotinib—ABCG2—lymph node—retroperitoneal cancer	0.000166	0.00218	CbGeAlD
Erlotinib—CYP1A1—lymph node—retroperitoneal cancer	0.000157	0.00207	CbGeAlD
Erlotinib—CYP2D6—testis—retroperitoneal cancer	0.000157	0.00206	CbGeAlD
Erlotinib—ABCB1—adrenal gland—retroperitoneal cancer	0.000136	0.00179	CbGeAlD
Erlotinib—ABCB1—testis—retroperitoneal cancer	0.000113	0.00148	CbGeAlD
Erlotinib—ABCB1—lymph node—retroperitoneal cancer	8.18e-05	0.00108	CbGeAlD
